PACAP38 increases vesicular monoamine transporter 2 (VMAT2) expression and attenuates methamphetamine toxicity Article

Guillot, TS, Richardson, JR, Wang, MZ et al. (2008). PACAP38 increases vesicular monoamine transporter 2 (VMAT2) expression and attenuates methamphetamine toxicity . 42(4), 423-434. 10.1016/j.npep.2008.04.003

Open Access International Collaboration

cited authors

  • Guillot, TS; Richardson, JR; Wang, MZ; Li, YJ; Taylor, TN; Ciliax, BJ; Zachrisson, O; Mercer, A; Miller, GW

sustainable development goals

authors

publication date

  • August 1, 2008

keywords

  • ADENYLATE-CYCLASE
  • BLOOD-BRAIN-BARRIER
  • CYCLASE-ACTIVATING POLYPEPTIDE
  • DOPAMINERGIC-NEURONS
  • Endocrinology & Metabolism
  • INDUCED NEUROTOXICITY
  • Life Sciences & Biomedicine
  • MICE LACKING
  • MICROGLIAL ACTIVATION
  • NEURONAL CELL-DEATH
  • Neurosciences
  • Neurosciences & Neurology
  • PARKINSONS-DISEASE
  • RAT MODEL
  • Science & Technology
  • astrogliosis
  • dopamine
  • microgliosis
  • neurotoxicity

Digital Object Identifier (DOI)

publisher

  • CHURCHILL LIVINGSTONE

start page

  • 423

end page

  • 434

volume

  • 42

issue

  • 4